138 related articles for article (PubMed ID: 10226764)
1. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs.
van der Lee R; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
Noll G; Lüscher TF
Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
[TBL] [Abstract][Full Text] [Related]
3. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
Sarsero D; Fujiwara T; Molenaar P; Angus JA
Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries.
Li JS; Schiffrin EL
Am J Hypertens; 1997 Jan; 10(1):94-100. PubMed ID: 9008253
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery.
van der Lee R; Pfaffendorf M; De Mey JG; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):74-9. PubMed ID: 10651150
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
Li JS; Schiffrin EL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
Nakamura Y; Ono H; Frohlich ED
Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
[TBL] [Abstract][Full Text] [Related]
8. Differential time course of the vasodilator action of various calcium antagonists.
van der Lee R; Kam KL; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1998; 12(6):607-12. PubMed ID: 9818292
[TBL] [Abstract][Full Text] [Related]
9. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
10. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Cremers B; Flesch M; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel.
Schmitt R; Clozel JP; Iberg N; Bühler FR
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1161-5. PubMed ID: 7627710
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
13. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
Brixius K; Mohr V; Müller-Ehmsen J; Hoischen S; Münch G; Schwinger RH
Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
[TBL] [Abstract][Full Text] [Related]
14. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
15. Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats.
Lacolley P; Poitevin P; Koen R; Levy BI
J Hypertens; 1998 Mar; 16(3):349-55. PubMed ID: 9557928
[TBL] [Abstract][Full Text] [Related]
16. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.
Badawi JK; Li H; Langbein S; Kwon ST; Kamp S; Bross S
Eur J Clin Pharmacol; 2006 May; 62(5):347-54. PubMed ID: 16602019
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonist.
Abernethy DR
Am J Cardiol; 1997 Aug; 80(4B):4C-11C. PubMed ID: 9286848
[TBL] [Abstract][Full Text] [Related]
19. Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats.
Tabet F; Savoia C; Schiffrin EL; Touyz RM
J Cardiovasc Pharmacol; 2004 Aug; 44(2):200-8. PubMed ID: 15243301
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of induced contraction in the isolated rat mesenteric vascular bed by Ro 40-5967, a novel calcium antagonist].
Sato Y; Watanabe H; Himori N
Nihon Yakurigaku Zasshi; 1995 Mar; 105(3):171-6. PubMed ID: 7721195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
